|
|
||||||||
Peripheral Nerve Laboratory, Mayo Medical School and Foundation, Rochester, MN 55905.
Twenty-seven patients with static or worsening chronic inflammatory-demyelinating polyradiculoneuropathy were randomly assigned to alternate day decremental prednisone therapy alone or with azathioprine (2 mg/kg) for 9 months. No statistically significant alterations were demonstrated between these treatment schedules.
Address correspondence and reprint requests to Dr. Dyck, Peripheral Nerve Laboratory, Mayo Medical School and Foundation, Rochester, MN 55905.
Supported in part by a Peripheral Neuropathy Clinical Center Grant from NINCDS (NS14304), a Center Grant from MDA. and Mayo, Borrhard, Upton, and Herrick Funds.
Accepted for publication November 30, 1984.
This article has been cited by other articles:
![]() |
M P T Lunn and H J Willison Diagnosis and treatment in inflammatory neuropathies Postgrad. Med. J., August 1, 2009; 85(1006): 437 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Lehmann, G. Meyer zu Horste, B. C. Kieseier, and H.-P. Hartung Review: Pathogenesis and treatment of immune-mediated neuropathies Therapeutic Advances in Neurological Disorders, July 1, 2009; 2(4): 261 - 281. [Abstract] [PDF] |
||||
![]() |
M P T Lunn and H J Willison Diagnosis and treatment in inflammatory neuropathies J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 249 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Fialho, Y-C Chan, D C Allen, M M Reilly, and R A C Hughes Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 544 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Overell and H. J Willison Chronic inflammatory demyelinating polyradiculoneuropathy: classification and treatment options Practical Neurology, April 1, 2006; 6(2): 102 - 110. [Full Text] [PDF] |
||||
![]() |
H. Koller, B. C. Kieseier, S. Jander, and H.-P. Hartung Chronic Inflammatory Demyelinating Polyneuropathy N. Engl. J. Med., March 31, 2005; 352(13): 1343 - 1356. [Full Text] [PDF] |
||||
![]() |
A. H. Ropper Current treatments for CIDP Neurology, April 22, 2003; 60(90083): S16 - 22. [Abstract] [Full Text] |
||||
![]() |
D. W. Zochodne, R. Auer, and M. J. Fritzler Longstanding ataxic demyelinating polyneuronopathy with a novel autoantibody Neurology, January 14, 2003; 60(1): 127 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Cornblath, V. Chaudhry, K. Carter, D. Lee, M. Seysedadr, M. Miernicki, and T. Joh Total neuropathy score: Validation and reliability study Neurology, November 1, 1999; 53(8): 1660 - 1660. [Abstract] [Full Text] |
||||
![]() |
G. Comi, R. Nemni, S. Amadio, G. Galardi, and L. Leocani Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies Multiple Sclerosis, April 1, 1997; 3(2): 93 - 97. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |